glp-1 weight loss injections Injection/ GLP-1 Injections for Medical Weight
Description
This is the ladder documented in the Wegovy prescribing information and mirrored in the STEP trial program
Heres what you should know about Wegovy coverage if you have a Blue Cross Blue Shield policy
Bonaca, M
According to the Semaglutide Treatment Effect in People with Obesity (STEP) program studies, people with overweight or obesity (without T2DM) who received semaglutide 2.4 mg and underwent lifestyle interventions experienced an average weight reduction of 14.7- 17.4% [116]
Can J Diabetes 2018;42:S316
